Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.25 USD | +2.62% | -10.83% | -51.21% |
05-10 | UBS Cuts Price Target on ACADIA Pharmaceuticals to $25 From $27, Keeps Buy Rating | MT |
05-10 | Oppenheimer Adjusts ACADIA Pharmaceuticals Price Target to $17 From $19, Maintains Perform Rating | MT |